id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT03120728
1:23:cancer
hepatocellular adenoma
1
[ "hepatocellular", "adenoma" ]
[ 3, 3 ]
NCT02579096
34:77:treatment
Patients with a history of prior solid organ / hematopoietic transplantation
1
[ "Patients", "with", "a", "history", "of", "prior", "solid", "organ", "/", "hematopoietic", "transplantation" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1 ]
NCT02574910
20:30:cancer
Evidence of active malignancy
1
[ "Evidence", "of", "active", "malignancy" ]
[ 0, 0, 0, 3 ]
NCT02169037
1:17:chronic_disease
vascular disease (1 point)
1
[ "vascular", "disease", "(", "1", "point", ")" ]
[ 2, 2, 0, 0, 0, 0 ]
NCT01754857
63:71:allergy_name
Subjects must not have a known history of hypersensitivity to mannitol
1
[ "Subjects", "must", "not", "have", "a", "known", "history", "of", "hypersensitivity", "to", "mannitol" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4 ]
NCT01976585
18:52:chronic_disease
Known history of human immunodeficiency virus (HIV)
1
[ "Known", "history", "of", "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02321501
,,,143:153:treatment,,
Negative serum or urine pregnancy test beta-Human Chorionic Gonadotropin (beta hCG) within 2 weeks prior to receiving the first dose of study medication for women of childbearing age
1
[ "Negative", "serum", "or", "urine", "pregnancy", "test", "beta-Human", "Chorionic", "Gonadotropin", "(", "beta", "hCG", ")", "within", "2", "weeks", "prior", "to", "receiving", "the", "first", "dose", "of", "study", "medication", "for", "women", "of", "childbearing", "age" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02012296
8:45:chronic_disease
Active psychiatric illness/social situations that would limit compliance with protocol requirements
1
[ "Active", "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "protocol", "requirements" ]
[ 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02169830
1:14:treatment,16:50:treatment,59:69:treatment
Nortriptyline: monoamine oxidase inhibitors (MAO) such as phenelzine
1
[ "Nortriptyline", ":", "monoamine", "oxidase", "inhibitors", "(", "MAO", ")", "such", "as", "phenelzine" ]
[ 1, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1 ]
NCT02203513
,,196:209:treatment
All subjects of reproductive potential must also agree to use both a barrier method and a second method of birth control during the course of the study and for four months after the last dose of study drug(s)
1
[ "All", "subjects", "of", "reproductive", "potential", "must", "also", "agree", "to", "use", "both", "a", "barrier", "method", "and", "a", "second", "method", "of", "birth", "control", "during", "the", "course", "of", "the", "study", "and", "for", "four", "months", "after", "the", "last", "dose", "of", "study", "drug", "(", "s", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02820350
1:4:chronic_disease
HIV
1
[ "HIV" ]
[ 2 ]
NCT00819208
15:24:treatment,41:53:treatment,57:66:treatment
No concurrent treatment with additional chemotherapy or radiation
1
[ "No", "concurrent", "treatment", "with", "additional", "chemotherapy", "or", "radiation" ]
[ 0, 0, 1, 0, 0, 1, 0, 1 ]
NCT01994538
29:50:treatment
Treatment initiated with an empiric antimicrobial to which the organism isolated in the urine culture is non-susceptible based on standard laboratory criteria
1
[ "Treatment", "initiated", "with", "an", "empiric", "antimicrobial", "to", "which", "the", "organism", "isolated", "in", "the", "urine", "culture", "is", "non-susceptible", "based", "on", "standard", "laboratory", "criteria" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02593123
24:34:cancer
Determination that the malignancy is high risk will be made by the investigator
1
[ "Determination", "that", "the", "malignancy", "is", "high", "risk", "will", "be", "made", "by", "the", "investigator" ]
[ 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01976169
20:54:chronic_disease
Known positive for human immunodeficiency virus (HIV)
1
[ "Known", "positive", "for", "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02304458
,,82:103:treatment,
Platelet count >= 75,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
1
[ "Platelet", "count", ">", "=", "75,000/mm^3", "(", "transfusion", "independent", ",", "defined", "as", "not", "receiving", "platelet", "transfusions", "for", "at", "least", "7", "days", "prior", "to", "enrollment", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01623167
1:32:treatment,42:45:treatment,47:58:treatment,73:89:treatment
Prior immunosuppressive therapy with any ATG, alemtuzumab, or high dose cyclophosphamide
1
[ "Prior", "immunosuppressive", "therapy", "with", "any", "ATG", ",", "alemtuzumab", ",", "or", "high", "dose", "cyclophosphamide" ]
[ 1, 1, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1 ]
NCT02538198
34:44:cancer,
Diagnosed or treated for another malignancy within 3 years prior to study enrollment
1
[ "Diagnosed", "or", "treated", "for", "another", "malignancy", "within", "3", "years", "prior", "to", "study", "enrollment" ]
[ 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT02746458
,173:192:treatment
Additional fracture, dislocations or soft tissue injuries to the study limb that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation
1
[ "Additional", "fracture", ",", "dislocations", "or", "soft", "tissue", "injuries", "to", "the", "study", "limb", "that", "would", "compromise", "the", "ability", "to", "weight", "bear", "as", "tolerated", "and", "initiate", "PT", "within", "28", "days", "of", "definitive", "fixation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02820350
17:39:treatment,56:67:treatment,71:91:treatment,
Patients with a solid organ transplant or those with a bone marrow or stem cell transplant in the previous 100 days or who have not engrafted
1
[ "Patients", "with", "a", "solid", "organ", "transplant", "or", "those", "with", "a", "bone", "marrow", "or", "stem", "cell", "transplant", "in", "the", "previous", "100", "days", "or", "who", "have", "not", "engrafted" ]
[ 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 1, 1, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01824836
102:113:treatment
Patients must have adequate hepatic, hematologic and renal functioning to be able to be administered anastrozole at the discretion of the treating physician
1
[ "Patients", "must", "have", "adequate", "hepatic", ",", "hematologic", "and", "renal", "functioning", "to", "be", "able", "to", "be", "administered", "anastrozole", "at", "the", "discretion", "of", "the", "treating", "physician" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02379377
1:6:cancer
Tumor confirmed by arteriography
1
[ "Tumor", "confirmed", "by", "arteriography" ]
[ 3, 0, 0, 0 ]
NCT02133885
6:35:treatment
more anti-hypertensive medications of different classes
1
[ "more", "anti-hypertensive", "medications", "of", "different", "classes" ]
[ 0, 1, 1, 0, 0, 0 ]
NCT01953900
53:65:treatment
Recovered from the acute toxic effects of all prior chemotherapy
1
[ "Recovered", "from", "the", "acute", "toxic", "effects", "of", "all", "prior", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02400255
1:24:treatment,29:36:treatment,40:43:cancer
Chemotherapeutic agents for therapy of AML
1
[ "Chemotherapeutic", "agents", "for", "therapy", "of", "AML" ]
[ 1, 1, 0, 1, 0, 3 ]
NCT02106650
,,80:89:treatment,
Male patients are to agree to use a barrier method of contraception from study treatment initiation until at least 90 days after the last administration of Folotyn
1
[ "Male", "patients", "are", "to", "agree", "to", "use", "a", "barrier", "method", "of", "contraception", "from", "study", "treatment", "initiation", "until", "at", "least", "90", "days", "after", "the", "last", "administration", "of", "Folotyn" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01597518
1:18:cancer,33:52:cancer,,103:135:cancer,139:174:cancer
Active malignancy or history of invasive malignancy within the last five years, with the exception of superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitely treated
1
[ "Active", "malignancy", "or", "history", "of", "invasive", "malignancy", "within", "the", "last", "five", "years", ",", "with", "the", "exception", "of", "superficial", "basal", "cell", "carcinoma", "or", "squamous", "cell", "carcinoma", "of", "the", "skin", "that", "has", "been", "definitely", "treated" ]
[ 3, 3, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0 ]
NCT02236013
13:30:treatment,
Subject has radiation therapy within 4 weeks prior to the first study dose
1
[ "Subject", "has", "radiation", "therapy", "within", "4", "weeks", "prior", "to", "the", "first", "study", "dose" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00285935
28:53:chronic_disease,55:63:chronic_disease,70:83:chronic_disease
Current DSM-5 diagnosis of Major Depressive Disorder, unipolar, with non-psychotic features
1
[ "Current", "DSM-5", "diagnosis", "of", "Major", "Depressive", "Disorder", ",", "unipolar", ",", "with", "non-psychotic", "features" ]
[ 0, 0, 0, 0, 2, 2, 2, 0, 2, 0, 0, 2, 0 ]
NCT02254863
24:61:treatment
Prior participation in any gene or regenerative cell therapy study
1
[ "Prior", "participation", "in", "any", "gene", "or", "regenerative", "cell", "therapy", "study" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 1, 0 ]
NCT02416102
22:35:chronic_disease
clinical evidence of cor pulmonale
1
[ "clinical", "evidence", "of", "cor", "pulmonale" ]
[ 0, 0, 0, 2, 2 ]
NCT03113825
1:27:treatment,31:41:treatment,44:48:treatment,52:56:treatment,64:74:treatment
Primary surgical treatment is lumpectomy + SLNB or ALND --or-- mastectomy + ALND
1
[ "Primary", "surgical", "treatment", "is", "lumpectomy", "+", "SLNB", "or", "ALND", "--", "or", "--", "mastectomy", "+", "ALND" ]
[ 1, 1, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 1, 0, 0 ]
NCT02566304
1:4:chronic_disease
HIV positive
1
[ "HIV", "positive" ]
[ 2, 0 ]
NCT02092324
,,,,234:251:chronic_disease
Subjects with inadequate liver (alanine aminotransferase [ALT]/serum glutamate pyruvate transaminase [SGPT] above 4 X upper limit of normal [ULN] or direct bilirubin 4 X ULN AND the lab abnormalities are felt to be due to underlying liver dysfunction)
1
[ "Subjects", "with", "inadequate", "liver", "(", "alanine", "aminotransferase", "[", "ALT", "]", "/serum", "glutamate", "pyruvate", "transaminase", "[", "SGPT", "]", "above", "4", "X", "upper", "limit", "of", "normal", "[", "ULN", "]", "or", "direct", "bilirubin", "4", "X", "ULN", "AND", "the", "lab", "abnormalities", "are", "felt", "to", "be", "due", "to", "underlying", "liver", "dysfunction", ")" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03150004
,,,,,165:168:cancer,172:188:chronic_disease,192:201:chronic_disease
Direct bilirubin ≤ 1.5 X the upper limit of the normal range (ULN), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3 X ULN unless related to AML or Gilbert syndrome or hemolysis
1
[ "Direct", "bilirubin", "≤", "1.5", "X", "the", "upper", "limit", "of", "the", "normal", "range", "(", "ULN", ")", ",", "alanine", "aminotransferase", "(", "ALT", ")", "and", "aspartate", "aminotransferase", "(", "AST", ")", "≤", "3", "X", "ULN", "unless", "related", "to", "AML", "or", "Gilbert", "syndrome", "or", "hemolysis" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 2, 2, 0, 2 ]
NCT02332850
39:57:treatment
must be > than four half-lives of the experimental agent
1
[ "must", "be", ">", "than", "four", "half-lives", "of", "the", "experimental", "agent" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02554903
,,101:110:treatment
Agreement to undertake monthly serum pregnancy tests during the study and up to 30 days after study treatment discontinuation
1
[ "Agreement", "to", "undertake", "monthly", "serum", "pregnancy", "tests", "during", "the", "study", "and", "up", "to", "30", "days", "after", "study", "treatment", "discontinuation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT01434316
76:84:treatment,130:144:treatment,130:135:cancer,160:166:treatment,288:297:allergy_name,392:407:treatment,429:437:treatment,441:469:treatment,510:533:treatment,,,,,653:675:treatment
Eligible patients in the dose escalation phases of the trial must agree to biopsies of normal skin, unless they undergo optional tumor biopsies; the mandatory biopsy requirement can be waived at the discretion of principal investigator in the event of any medical contraindication (e.g. lidocaine allergy); patients enrolled to the expanded cohorts must agree to tumor sampling; patients on anticoagulation must be able to hold warfarin or low molecular weight heparin for a sufficient amount of time to make skin and tumor biopsies safe to perform; PT/INR and PTT should be =< 1.5 times the institutional upper limit of normal prior to performance of skin or tumor biopsies, with values re-checked after the eligibility screen as medically indicated
1
[ "Eligible", "patients", "in", "the", "dose", "escalation", "phases", "of", "the", "trial", "must", "agree", "to", "biopsies", "of", "normal", "skin", ",", "unless", "they", "undergo", "optional", "tumor", "biopsies", ";", "the", "mandatory", "biopsy", "requirement", "can", "be", "waived", "at", "the", "discretion", "of", "principal", "investigator", "in", "the", "event", "of", "any", "medical", "contraindication", "(", "e.g", ".", "lidocaine", "allergy", ")", ";", "patients", "enrolled", "to", "the", "expanded", "cohorts", "must", "agree", "to", "tumor", "sampling", ";", "patients", "on", "anticoagulation", "must", "be", "able", "to", "hold", "warfarin", "or", "low", "molecular", "weight", "heparin", "for", "a", "sufficient", "amount", "of", "time", "to", "make", "skin", "and", "tumor", "biopsies", "safe", "to", "perform", ";", "PT/INR", "and", "PTT", "should", "be", "=", "<", "1.5", "times", "the", "institutional", "upper", "limit", "of", "normal", "prior", "to", "performance", "of", "skin", "or", "tumor", "biopsies", ",", "with", "values", "re-checked", "after", "the", "eligibility", "screen", "as", "medically", "indicated" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 1, 0, 0, 3, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02439450
89:102:treatment,125:138:treatment,141:151:treatment
radiographically per RECIST 1.1 at first imaging assessment, and will begin maintenance immunotherapy with standard of care pembrolizumab ± pemetrexed
1
[ "radiographically", "per", "RECIST", "1.1", "at", "first", "imaging", "assessment", ",", "and", "will", "begin", "maintenance", "immunotherapy", "with", "standard", "of", "care", "pembrolizumab", "±", "pemetrexed" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1 ]
NCT02397083
9:22:chronic_disease
Genital actinomycosis
1
[ "Genital", "actinomycosis" ]
[ 0, 2 ]
NCT01763970
1:19:cancer
tumor malignancies must meet certain criteria to be eligible
1
[ "tumor", "malignancies", "must", "meet", "certain", "criteria", "to", "be", "eligible" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT03165227
11:24:treatment
bilateral salpingectomy
1
[ "bilateral", "salpingectomy" ]
[ 0, 1 ]
NCT02263274
7:23:allergy_name
Known adhesive allergy
1
[ "Known", "adhesive", "allergy" ]
[ 0, 4, 4 ]
NCT02514083
1:24:chronic_disease
Impaired renal function
1
[ "Impaired", "renal", "function" ]
[ 2, 2, 2 ]
NCT02804230
1:39:chronic_disease
Lesions in the brainstem or cerebellum
1
[ "Lesions", "in", "the", "brainstem", "or", "cerebellum" ]
[ 2, 2, 2, 2, 2, 2 ]
NCT01703949
,63:75:treatment
Patients must be anticipated to complete at least 2 cycles of chemotherapy on study
1
[ "Patients", "must", "be", "anticipated", "to", "complete", "at", "least", "2", "cycles", "of", "chemotherapy", "on", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT02998918
21:44:treatment,48:65:treatment,82:94:chronic_disease
Taking prescription anti-inflammatory drugs or supplements/drugs that may affect inflammation
1
[ "Taking", "prescription", "anti-inflammatory", "drugs", "or", "supplements/drugs", "that", "may", "affect", "inflammation" ]
[ 0, 0, 1, 1, 0, 1, 0, 0, 0, 2 ]
NCT02474199
85:97:treatment,,
For subjects with elevated liver tests as defined above, local pathology reading of liver biopsy 6-10 days after darTregs infusion is without AR according to Banff criteria
1
[ "For", "subjects", "with", "elevated", "liver", "tests", "as", "defined", "above", ",", "local", "pathology", "reading", "of", "liver", "biopsy", "6-10", "days", "after", "darTregs", "infusion", "is", "without", "AR", "according", "to", "Banff", "criteria" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01964404
22:31:chronic_disease,,
Positive symptoms of psychosis (> 4 [moderate]) on any item of the Positive and Negative Syndrome Scale psychosis subscale (once abstinent) except for the hallucination item
1
[ "Positive", "symptoms", "of", "psychosis", "(", ">", "4", "[", "moderate", "]", ")", "on", "any", "item", "of", "the", "Positive", "and", "Negative", "Syndrome", "Scale", "psychosis", "subscale", "(", "once", "abstinent", ")", "except", "for", "the", "hallucination", "item" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03137758
18:48:treatment
standard of care androgen deprivation treatment
1
[ "standard", "of", "care", "androgen", "deprivation", "treatment" ]
[ 0, 0, 0, 1, 1, 1 ]
NCT02566304
55:65:cancer
Active involvement of the central nervous system with malignancy
1
[ "Active", "involvement", "of", "the", "central", "nervous", "system", "with", "malignancy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT03179397
17:34:chronic_disease,42:52:chronic_disease,66:87:chronic_disease
Clinical severe corneal dystrophy (e.g., epithelial, stromal, or endothelial dystrophy)
1
[ "Clinical", "severe", "corneal", "dystrophy", "(", "e.g.", ",", "epithelial", ",", "stromal", ",", "or", "endothelial", "dystrophy", ")" ]
[ 0, 0, 2, 2, 0, 0, 0, 2, 0, 0, 0, 0, 2, 2, 0 ]
NCT02536794
,36:48:treatment
have received at least one line of chemotherapy in the metastatic setting
1
[ "have", "received", "at", "least", "one", "line", "of", "chemotherapy", "in", "the", "metastatic", "setting" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT03113136
51:62:chronic_disease,64:70:chronic_disease,75:88:chronic_disease
unstable or significant medical condition such as respiratory, kidney, or liver disease that could potentially affect biomarker data
1
[ "unstable", "or", "significant", "medical", "condition", "such", "as", "respiratory", ",", "kidney", ",", "or", "liver", "disease", "that", "could", "potentially", "affect", "biomarker", "data" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT03175978
16:24:chronic_disease,30:46:chronic_disease,66:74:chronic_disease
Any history of epilepsy or a seizure disorder or any known prior seizures
1
[ "Any", "history", "of", "epilepsy", "or", "a", "seizure", "disorder", "or", "any", "known", "prior", "seizures" ]
[ 0, 0, 0, 2, 0, 0, 2, 2, 0, 0, 0, 0, 2 ]
NCT02227199
35:69:chronic_disease
Patients known to be positive for human immunodeficiency virus (HIV)
1
[ "Patients", "known", "to", "be", "positive", "for", "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02963831
15:33:cancer,50:77:treatment,114:139:cancer,143:177:cancer
Subjects with peritoneal disease who have failed prior standard chemotherapy and have histologic confirmation of epithelial ovarian cancer or metastatic colorectal cancer (CRC) including cancer originating from the appendix
1
[ "Subjects", "with", "peritoneal", "disease", "who", "have", "failed", "prior", "standard", "chemotherapy", "and", "have", "histologic", "confirmation", "of", "epithelial", "ovarian", "cancer", "or", "metastatic", "colorectal", "cancer", "(", "CRC", ")", "including", "cancer", "originating", "from", "the", "appendix" ]
[ 0, 0, 3, 3, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 3, 3, 3, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02334865
11:31:chronic_disease,42:51:treatment,55:80:treatment
Any prior autoimmune disorders requiring cytotoxic or immunosuppressive therapy or autoimmune disorders with visceral involvement
1
[ "Any", "prior", "autoimmune", "disorders", "requiring", "cytotoxic", "or", "immunosuppressive", "therapy", "or", "autoimmune", "disorders", "with", "visceral", "involvement" ]
[ 0, 0, 2, 2, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT03187028
1:26:chronic_disease
severe emotional distress
1
[ "severe", "emotional", "distress" ]
[ 2, 2, 2 ]
NCT01618357
14:26:treatment,19:26:treatment,28:41:treatment,43:59:treatment,64:87:treatment,,138:147:treatment,152:161:treatment
Last dose of chemotherapy, immunotherapy, biologic therapy, or investigational therapy, was less than 14 days prior to protocol therapy (radiation and veliparib)
1
[ "Last", "dose", "of", "chemotherapy", ",", "immunotherapy", ",", "biologic", "therapy", ",", "or", "investigational", "therapy", ",", "was", "less", "than", "14", "days", "prior", "to", "protocol", "therapy", "(", "radiation", "and", "veliparib", ")" ]
[ 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0 ]
NCT02573246
1:24:chronic_disease
Intellectual disability
1
[ "Intellectual", "disability" ]
[ 2, 2 ]
NCT01873131
48:57:treatment
whose parent/guardian is unable to comply with treatment, home care or follow-up visits
1
[ "whose", "parent/guardian", "is", "unable", "to", "comply", "with", "treatment", ",", "home", "care", "or", "follow-up", "visits" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT01962415
8:32:chronic_disease
Severe acquired aplastic anemia
1
[ "Severe", "acquired", "aplastic", "anemia" ]
[ 0, 2, 2, 2 ]
NCT02085941
36:51:cancer,60:70:cancer
must have histologically confirmed malignant tumor that is metastatic or unresectable and for which standard curative or palliative measures do not exist or are no longer effective
1
[ "must", "have", "histologically", "confirmed", "malignant", "tumor", "that", "is", "metastatic", "or", "unresectable", "and", "for", "which", "standard", "curative", "or", "palliative", "measures", "do", "not", "exist", "or", "are", "no", "longer", "effective" ]
[ 0, 0, 0, 0, 3, 3, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03003780
1:24:chronic_disease
COPD or HF exacerbation in the previous month
1
[ "COPD", "or", "HF", "exacerbation", "in", "the", "previous", "month" ]
[ 2, 2, 2, 2, 0, 0, 0, 0 ]
NCT02706249
13:25:chronic_disease,,,
Presence of coagulopathy (PT or PTT> 1.2 x upper limit of normal)
1
[ "Presence", "of", "coagulopathy", "(", "PT", "or", "PTT", ">", "1.2", "x", "upper", "limit", "of", "normal", ")" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01660607
1:12:chronic_disease
hepatitis B sAg
1
[ "hepatitis", "B", "sAg" ]
[ 2, 2, 0 ]
NCT02555189
12:21:chronic_disease,25:44:chronic_disease,74:83:chronic_disease,87:108:chronic_disease
History of pituitary or adrenal dysfunction, active or symptomatic viral hepatitis or chronic liver disease
1
[ "History", "of", "pituitary", "or", "adrenal", "dysfunction", ",", "active", "or", "symptomatic", "viral", "hepatitis", "or", "chronic", "liver", "disease" ]
[ 0, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2 ]
NCT02575404
117:130:treatment
Patients who have radiographic progression using Response Evaluation Criteria In Solid Tumors (RECIST) currently on pembrolizumab are also eligible
1
[ "Patients", "who", "have", "radiographic", "progression", "using", "Response", "Evaluation", "Criteria", "In", "Solid", "Tumors", "(", "RECIST", ")", "currently", "on", "pembrolizumab", "are", "also", "eligible" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02551679
39:72:chronic_disease
Severe concurrent disease (other than Peripheral Vascular Disease (PAD)
1
[ "Severe", "concurrent", "disease", "(", "other", "than", "Peripheral", "Vascular", "Disease", "(", "PAD", ")" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT03037385
39:61:chronic_disease
Clinically significant, uncontrolled, cardiovascular disease
1
[ "Clinically", "significant", ",", "uncontrolled", ",", "cardiovascular", "disease" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT02091999
1:13:treatment
chemotherapy
1
[ "chemotherapy" ]
[ 1 ]
NCT03008603
26:38:chronic_disease
Subject with significant coagulopathy
1
[ "Subject", "with", "significant", "coagulopathy" ]
[ 0, 0, 0, 2 ]
NCT02339948
9:16:chronic_disease,20:39:chronic_disease,64:73:treatment
Current medical or psychiatric illness that may interfere with treatment completion and followup
1
[ "Current", "medical", "or", "psychiatric", "illness", "that", "may", "interfere", "with", "treatment", "completion", "and", "followup" ]
[ 0, 2, 0, 2, 2, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02515110
,,135:144:treatment
Women of child-bearing potential (WCBP) must agree to use a medically accepted form of pregnancy prevention for the duration of study treatment
1
[ "Women", "of", "child-bearing", "potential", "(", "WCBP", ")", "must", "agree", "to", "use", "a", "medically", "accepted", "form", "of", "pregnancy", "prevention", "for", "the", "duration", "of", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02488967
1:45:treatment,,74:92:treatment,115:131:treatment
Chronic daily treatment with corticosteroids with a dose of >= 10 mg/day methylprednisolone equivalent (excluding inhaled steroids)
1
[ "Chronic", "daily", "treatment", "with", "corticosteroids", "with", "a", "dose", "of", ">", "=", "10", "mg/day", "methylprednisolone", "equivalent", "(", "excluding", "inhaled", "steroids", ")" ]
[ 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 1, 0 ]
NCT01983462
8:24:treatment,26:34:treatment,36:41:treatment,51:62:treatment,64:72:treatment,74:81:treatment,83:92:treatment
Taking cox-2 inhibitors (Celebrex, Vioxx, etc) or allopurinol (Zyloprim, Lopurin, Allopurin)
1
[ "Taking", "cox-2", "inhibitors", "(", "Celebrex", ",", "Vioxx", ",", "etc", ")", "or", "allopurinol", "(", "Zyloprim", ",", "Lopurin", ",", "Allopurin", ")" ]
[ 0, 1, 1, 0, 1, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0 ]
NCT01614990
8:18:chronic_disease
Severe depression as determined by the investigator
1
[ "Severe", "depression", "as", "determined", "by", "the", "investigator" ]
[ 0, 2, 0, 0, 0, 0, 0 ]
NCT02776761
5:20:treatment,,
For corticosteroids, this will mean prednisone, or equivalent, greater than or equal to 0.5 mg/kg/day
1
[ "For", "corticosteroids", ",", "this", "will", "mean", "prednisone", ",", "or", "equivalent", ",", "greater", "than", "or", "equal", "to", "0.5", "mg/kg/day" ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02323191
31:55:cancer,
Participants has a history of hematological malignancy within the last 5 years prior to study entry
1
[ "Participants", "has", "a", "history", "of", "hematological", "malignancy", "within", "the", "last", "5", "years", "prior", "to", "study", "entry" ]
[ 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02031250
15:31:chronic_disease
Patients with active infection
1
[ "Patients", "with", "active", "infection" ]
[ 0, 0, 2, 2 ]
NCT02120222
14:30:chronic_disease
Uncontrolled active infection within one week prior to first dose
1
[ "Uncontrolled", "active", "infection", "within", "one", "week", "prior", "to", "first", "dose" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT01512888
,,36:45:treatment,71:91:treatment,108:138:treatment
Less than 300 CD3+ T-cells by flow cytometry or higher if evidence of maternal engraftment as supported by peripheral blood FISH analysis for XY and XX
1
[ "Less", "than", "300", "CD3+", "T-cells", "by", "flow", "cytometry", "or", "higher", "if", "evidence", "of", "maternal", "engraftment", "as", "supported", "by", "peripheral", "blood", "FISH", "analysis", "for", "XY", "and", "XX" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0 ]
NCT02393157
56:94:cancer
Patients in first relapse or primary induction failure CD20 positive B-cell leukemia/lymphoma
1
[ "Patients", "in", "first", "relapse", "or", "primary", "induction", "failure", "CD20", "positive", "B-cell", "leukemia/lymphoma" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3 ]
NCT02474199
31:57:cancer,65:76:cancer,78:83:cancer,87:100:cancer
History of adequately treated in-situ cervical carcinoma and/or skin cancer (basal or squamous cell) will be permitted
1
[ "History", "of", "adequately", "treated", "in-situ", "cervical", "carcinoma", "and/or", "skin", "cancer", "(", "basal", "or", "squamous", "cell", ")", "will", "be", "permitted" ]
[ 0, 0, 0, 0, 3, 3, 3, 0, 3, 3, 0, 3, 0, 3, 3, 0, 0, 0, 0 ]
NCT00739362
1:31:chronic_disease,33:58:chronic_disease,60:68:chronic_disease,70:97:chronic_disease,99:107:chronic_disease,122:133:chronic_disease
Central nervous system disease (cerebrovascular accidents, dementia, neurodegenerative disorders, epilepsy or history of head injury)
1
[ "Central", "nervous", "system", "disease", "(", "cerebrovascular", "accidents", ",", "dementia", ",", "neurodegenerative", "disorders", ",", "epilepsy", "or", "history", "of", "head", "injury", ")" ]
[ 2, 2, 2, 2, 0, 2, 2, 0, 2, 0, 2, 2, 0, 2, 0, 0, 0, 2, 2, 0 ]
NCT00357565
,84:100:treatment,,
All patients must be in CR as defined by hematological recovery, AND <5% blasts by light microscopy within the bone marrow with a cellularity of ≥15%
1
[ "All", "patients", "must", "be", "in", "CR", "as", "defined", "by", "hematological", "recovery", ",", "AND", "<", "5", "%", "blasts", "by", "light", "microscopy", "within", "the", "bone", "marrow", "with", "a", "cellularity", "of", "≥15", "%" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03004170
96:99:chronic_disease,
Report engaging in one or more occasions of condomless anal and/or vaginal intercourse with an HIV-negative or unknown HIV serostatus sex partner in the 3 months prior to study enrollment
1
[ "Report", "engaging", "in", "one", "or", "more", "occasions", "of", "condomless", "anal", "and/or", "vaginal", "intercourse", "with", "an", "HIV-negative", "or", "unknown", "HIV", "serostatus", "sex", "partner", "in", "the", "3", "months", "prior", "to", "study", "enrollment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03132415
1:4:chronic_disease
HIV-positive
1
[ "HIV-positive" ]
[ 2 ]
NCT02833792
12:29:cancer
History of cerebral neoplasm
1
[ "History", "of", "cerebral", "neoplasm" ]
[ 0, 0, 3, 3 ]
NCT02350764
57:85:treatment
There is no restriction on the number of prior lines of systemic anti-cancer therapy
1
[ "There", "is", "no", "restriction", "on", "the", "number", "of", "prior", "lines", "of", "systemic", "anti-cancer", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02131467
1:10:treatment
efavirenz
1
[ "efavirenz" ]
[ 1 ]
NCT00670358
,,,,80:88:cancer
Alkaline phosphatase ≤ 3 times ULN (5 times ULN if direct liver involvement by lymphoma)
1
[ "Alkaline", "phosphatase", "≤", "3", "times", "ULN", "(", "5", "times", "ULN", "if", "direct", "liver", "involvement", "by", "lymphoma", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0 ]
NCT01754779
,,36:59:chronic_disease
high pH as >6.40 in the absence of urinary tract infection
1
[ "high", "pH", "as", ">", "6.40", "in", "the", "absence", "of", "urinary", "tract", "infection" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02253316
22:39:chronic_disease
clinically important autonomic disease
1
[ "clinically", "important", "autonomic", "disease" ]
[ 0, 0, 2, 2 ]
NCT02844907
13:28:chronic_disease
Significant hepatic disease
1
[ "Significant", "hepatic", "disease" ]
[ 0, 2, 2 ]
NCT03001882
25:58:cancer
Patients with untreated central nervous system metastases
1
[ "Patients", "with", "untreated", "central", "nervous", "system", "metastases" ]
[ 0, 0, 0, 3, 3, 3, 3 ]
NCT01994382
24:42:cancer,38:42:cancer,39:42:cancer,95:98:cancer,99:101:cancer,103:106:cancer,109:113:cancer,126:131:cancer,133:144:cancer,146:149:cancer,194:197:cancer,198:201:cancer,203:207:cancer,212:216:cancer,223:225:cancer,226:228:cancer
Histological evidence: FL Grade 1-3A/iNHL, with relapsed or refractory disease (iNHL includes LPL/WM, MZL); aNHL, defined as DLBCL, FL Grade 3B, MCL, and transformed NHL with relapsed disease; CLL/SLL, PTCL, or CTCL (with MF/SS) with relapsed or refractory
1
[ "Histological", "evidence", ":", "FL", "Grade", "1-3A/iNHL", ",", "with", "relapsed", "or", "refractory", "disease", "(", "iNHL", "includes", "LPL/WM", ",", "MZL", ")", ";", "aNHL", ",", "defined", "as", "DLBCL", ",", "FL", "Grade", "3B", ",", "MCL", ",", "and", "transformed", "NHL", "with", "relapsed", "disease", ";", "CLL/SLL", ",", "PTCL", ",", "or", "CTCL", "(", "with", "MF/SS", ")", "with", "relapsed", "or", "refractory" ]
[ 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 3, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT02474199
9:27:cancer
without cholangiocarcinoma morphology
1
[ "without", "cholangiocarcinoma", "morphology" ]
[ 0, 3, 0 ]
NCT02606045
1:8:treatment,
Surgery within the past 8 weeks
1
[ "Surgery", "within", "the", "past", "8", "weeks" ]
[ 1, 0, 0, 0, 0, 0 ]